Congress Blames Insurance Executives for Rising US Health
The congressional hearing highlighted that US health costs blame insurance practices as a significant factor in the ongoing debate over rising healthcare
Richard Pazdur FDA retirement: Lead drug regulator steps
Richard Pazdur FDA retirement marks the end of a significant era in oncology leadership, raising questions about future directions for the agency’s drug